Skip to main content
Equibles

HQL · abrdn Life Sciences Investors

Track HQL — free

Use HQL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HQL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$17.78 +0.42 (+2.42%)
Rebalance outlook locked
Market Cap
$527.88M
Shares
30.41M
Volume · Nov 6 35.11K Avg daily vol (3M) 132.55K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$17.36 Open$18.36 Day$17.30–18.36 52W close$15.87–22.67 Avg vol 30d122K Short int193K · 0.6% of shares · 1.4d Short vol58% DataJan 2020–Nov 2026

Latest documents

2026
Apr 7
Proxy statement DEF 14A Meeting May 27, 2026
Proxy statement AI summary on its way
2025
2024
2023
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
12.2%
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
+10.4%
Trailing year
Short interest
0.6%
Latest settlement · 1.4 days to cover
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Neutral Sentiment Bearish Fundamentals Limited Quant / Vol Low
Market backdrop VIX 28.2 · fear Equity put/call 0.89
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −5%
below
Price vs 50-day avg −8%
below
RSI (14) 41
neutral
MACD trend Positive
52-week position 22%
mid-range
Momentum
relative strength
Neutral
1-month return 0%
trailing
6-month return −2%
trailing
YTD return +3%
this year
Relative strength −2%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $19 › 200d $18 — 50d above 200d
Institutional flow Distributing
42 of 86 funds reported for Sep 30 · net -921 sh shares · +8 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.63% of shares out · ▲ +70.8% MoM · 1.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
86 holders — mid 3-yr range
Squeeze score 42
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Low
Volatility 25%
annualized · 1-yr
Max drawdown −26%
past year
ATR 3.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
1 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−5% Neutral
Price vs 50-day avg
−8% Bearish
RSI (14)
41 Neutral
MACD trend
Positive Bullish
52-week position
22% Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $19 › 200d $18 — 50d above 200d
Institutional flow Distributing
42 of 86 funds reported for Sep 30 · net -921 sh shares · +8 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.63% of shares out · ▲ +70.8% MoM · 1.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
86 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $16 Now $17 · 22% Range high $23
vs 200-day avg -5% vs 50-day avg -8%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Asset Management — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
HQL
abrdn Life Sciences Investors
this stock
$527.88M +3.5% — — 0.6%
BLK
BlackRock, Inc.
 $379.37B +9.4% +16.2% 26.7 0.7%
BN
BROOKFIELD Corp
 $93.22B -9.0% — — 0.0%
BX
Blackstone Inc.
 $89.94B -22.3% +9.2% 26.9 2.5%
KKR
KKR & Co. Inc.
 $88.24B -22.9% -11.0% — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
90
% held
25.9%
Reported
42 of 86
Top holder
MORGAN STANLEY
Held Float
View
Held by Funds
Fund positions
6
View
Short & Settlement
Short Interest Rising
Shares short
192.7K
Days to cover
1.4d
Change
+79.8K sh
View
Short Volume
Short vol %
58%
As of
Nov 5, 2026
Short Total
View
Fails to Deliver
FTD shares
74
Value
$1.4K
As of
Sep 28, 2026
View
Off-Exchange
Off-exchange %
61.0%
Week of
Sep 28, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
DEF 14A
Filed
Apr 7, 2026
This year
1
View

Performance

5D 20D 120D MTD YTD
HQL -7.4% -0.4% -2.4% -5.9% +3.5%
SPY -4.7% -5.3% -0.8% -3.0% +7.5%
vs SPY -2.6% +4.9% -1.5% -2.9% -4.0%

Capital returns

Latest dividend
$0.62 / share · ex Aug 24, 2026
Raised 10.7%
Paid (TTM)
$2.24 / share · 4 payouts
Dividend yield (TTM, derived)
12.90%
Full dividend history

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 884121 CUSIP 87911K100 13F (30d) 59 filings 41 filers Investor relations